Prescribing Pattern of Drugs Used in Chronic Liver Disease with Co Morbid Conditions and Assessment of Severity using MELD Score: A Prospective Observational Study
Abstract
Objectives: To study the prescribing pattern of drugs & its use in the treatment of CLD & assess the pattern of co-morbidities associated with CLD. To Study the mortality rate of the patient using MELD score at a department of general medicine at Osmania general Hospital to produce a result which would aid better rational drug use and improve quality of life.
Methodology: A Prospective, observational study was carried out at OGH for a period of 6 months in 100 old patients. Population of either sex or ≥ 18 years of age were included.
Conclusion: There is a considerable scope for improving prescribing pattern in CLD by minimizing the use, reduction of doses of drugs to reduce the consequence of hepatotoxicity and Antibiotic Resistance. The prognostic impact of individual comorbidities, on the other hand, may point to areas where cirrhosis and comorbid diseases interact. Studies of individual comorbidities may therefore improve our understanding of the pathophysiology of cirrhosis. MELD showed that the subjects were less likely to get a Liver transplant.
Keywords: Chronic liver disease (CLD), Model for end stage liver disease (MELD), Diabetes Mellitus (DM), hypertension (HTN)
Downloads
References
2. Namratha A Desai, Kishan P Kotak, Snehal S Patel, “Investigation on epidemiology and etiology of liver diseases and characterization of its association with various factors” International Journal of Pharmacy. Feb 2015; (4):102- 106.
3. Peter Jepsen, “Comorbidity in cirrhosis” World Journal of Gastroenterology, June 2014.
4. Jan A. Roth, Carl Chrobak, Sabine Schädelin, Balthasar L. Hug,, “MELD score as a predictor of mortality, length of hospital stay, and disease burden”Wolters Kluwer Health, Inc. 2017
5. Deepak N. Amarapurkar, “Prescribing Medications in Patients with Decompensated Liver Cirrhosis”.International Journal of Hepatology, 2011.
6. Arathy.P.C, Vishak Mohan, Al-Muneer.S, Dhanya.A.H, “A Prospective and Observational study on pattern of comorbid conditions in CLD patients with Drug use pattern, and assessment of severity using MELD score”. Indian Research Journal of Pharmacy and Science, 2016.
7. Sathish Kumar V, Bhavana P, Supriya.CH, Abdul Rahaman.SK, ‘Prevalence and Drug Utilization Pattern in Hepatic Impairment Patients at a Tertiary Care Hospital”. International Journal of Science and Research (IJSR), 2017.
8. Jan Roth A, Andreas F. Widmer, Sarah Tschudin-Sutter, Marc Dangel, Manuel Battegay, Balthasar Hug.L, “The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study”. Wolters Kluwer Health, Inc 2017.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.